Adc Therapeutics Sa Stock Market Value
| ADCT Stock | USD 4.33 0.28 6.91% |
| Symbol | ADC |
Is there potential for Communications Equipment market expansion? Will ADC introduce new products? Factors like these will boost the valuation of ADC Therapeutics. If investors know ADC will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about ADC Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.41) | Revenue Per Share | Quarterly Revenue Growth (0.11) | Return On Assets | Return On Equity |
Understanding ADC Therapeutics requires distinguishing between market price and book value, where the latter reflects ADC's accounting equity. The concept of intrinsic value - what ADC Therapeutics' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push ADC Therapeutics' price substantially above or below its fundamental value.
Understanding that ADC Therapeutics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether ADC Therapeutics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, ADC Therapeutics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
ADC Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ADC Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ADC Therapeutics.
| 12/04/2025 |
| 03/04/2026 |
If you would invest 0.00 in ADC Therapeutics on December 4, 2025 and sell it all today you would earn a total of 0.00 from holding ADC Therapeutics SA or generate 0.0% return on investment in ADC Therapeutics over 90 days. ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates for patients suffering ... More
ADC Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ADC Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess ADC Therapeutics SA upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 22.62 | |||
| Value At Risk | (7.06) | |||
| Potential Upside | 8.03 |
ADC Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for ADC Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ADC Therapeutics' standard deviation. In reality, there are many statistical measures that can use ADC Therapeutics historical prices to predict the future ADC Therapeutics' volatility.| Risk Adjusted Performance | 0.0055 | |||
| Jensen Alpha | (0.06) | |||
| Total Risk Alpha | (0.25) | |||
| Treynor Ratio | (0.03) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of ADC Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
ADC Therapeutics March 4, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0055 | |||
| Market Risk Adjusted Performance | (0.02) | |||
| Mean Deviation | 3.28 | |||
| Coefficient Of Variation | (26,005) | |||
| Standard Deviation | 4.6 | |||
| Variance | 21.17 | |||
| Information Ratio | (0.01) | |||
| Jensen Alpha | (0.06) | |||
| Total Risk Alpha | (0.25) | |||
| Treynor Ratio | (0.03) | |||
| Maximum Drawdown | 22.62 | |||
| Value At Risk | (7.06) | |||
| Potential Upside | 8.03 | |||
| Skewness | 0.095 | |||
| Kurtosis | 1.52 |
ADC Therapeutics Backtested Returns
ADC Therapeutics appears to be moderately volatile, given 3 months investment horizon. ADC Therapeutics retains Efficiency (Sharpe Ratio) of 0.0746, which signifies that the company had a 0.0746 % return per unit of risk over the last 3 months. We have found twenty-four technical indicators for ADC Therapeutics, which you can use to evaluate the volatility of the firm. Please makes use of ADC Therapeutics' variance of 21.17, and Market Risk Adjusted Performance of (0.02) to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, ADC Therapeutics holds a performance score of 5. The firm owns a Beta (Systematic Risk) of 0.85, which signifies possible diversification benefits within a given portfolio. ADC Therapeutics returns are very sensitive to returns on the market. As the market goes up or down, ADC Therapeutics is expected to follow. Please check ADC Therapeutics' potential upside, and the relationship between the jensen alpha and rate of daily change , to make a quick decision on whether ADC Therapeutics' current price history will revert.
Auto-correlation | -0.32 |
Poor reverse predictability
ADC Therapeutics SA has poor reverse predictability. Overlapping area represents the amount of predictability between ADC Therapeutics time series from 4th of December 2025 to 18th of January 2026 and 18th of January 2026 to 4th of March 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ADC Therapeutics price movement. The serial correlation of -0.32 indicates that nearly 32.0% of current ADC Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.32 | |
| Spearman Rank Test | 0.04 | |
| Residual Average | 0.0 | |
| Price Variance | 0.06 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for ADC Stock Analysis
When running ADC Therapeutics' price analysis, check to measure ADC Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ADC Therapeutics is operating at the current time. Most of ADC Therapeutics' value examination focuses on studying past and present price action to predict the probability of ADC Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ADC Therapeutics' price. Additionally, you may evaluate how the addition of ADC Therapeutics to your portfolios can decrease your overall portfolio volatility.